TIDMBVXP

RNS Number : 0016V

BioVentix PLC

31 March 2023

Bioventix plc

("Bioventix" or the "Company")

Director/PDMR Shareholding

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, was notified on 31 March 2023 of the following transactions in its ordinary shares of 5 pence each ("Ordinary Shares"):

 
 Director               Role             Ordinary         Average               Ordinary       Percentage 
                                           Shares      sale price    Shares subsequently        of issued 
                                             sold    per Ordinary                   held    share capital 
                                                            Share                            subsequently 
                                                                                                     held 
 Ian Nicholson 
  and Persons           Non-Executive 
  Closely Associated     Chairman           2,500           3,900                 13,000             0.2% 
                       ---------------  ---------  --------------  ---------------------  ---------------

The notifications below, which have been made in accordance with the requirements of the Market Abuse Regulation, provide further details.

For further information please contact:

 
 Bioventix plc                                         Tel: 01252 728 001 
  Peter Harrison             Chief Executive Officer 
  Bruce Hiscock              Chief Financial Officer 
 
 finnCap Ltd                                           Tel: 020 7220 0500 
  Geoff Nash/Simon Hicks     Corporate Finance 
  Alice Lane                 ECM

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial responsibilities 
       ("PDMR") / person closely associated ("PCA") 
 a)   Name                             Ian Nicholson 
     -------------------------------  ---------------------------------- 
 2.   Reason for the Notification 
     ------------------------------------------------------------------- 
 a)   Position/status                  Chairman 
     -------------------------------  ---------------------------------- 
 b)   Initial notification/Amendment   Initial notification 
     -------------------------------  ---------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------- 
 a)   Name                             Bioventix plc 
     -------------------------------  ---------------------------------- 
 b)   LEI                              213800225MHX7LZQY108 
     -------------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------- 
 a)   Description of the               Ordinary Shares of 5 pence each 
       Financial instrument, 
       type of instrument 
      Identification code              GB00B4QVDF07 
     -------------------------------  ---------------------------------- 
 b)   Nature of the transaction        Sale of Ordinary Shares 
     -------------------------------  ---------------------------------- 
 c)   Price(s) and volume(s)            Price(s)   Volume(s) 
                                         3,877p     1,000 
                                                   ---------- 
     -------------------------------  ---------------------------------- 
 d)        Aggregated information:     See 4(c) 
             *    Aggregated volume 
 
 
             *    Price 
     -------------------------------  ---------------------------------- 
 e)   Date of the transaction          31 March 2023 
     -------------------------------  ---------------------------------- 
 f)   Place of the transaction         London Stock Exchange, AIM Market 
                                        (XLON) 
     -------------------------------  ---------------------------------- 
 
 
 1    Details of the person discharging managerial responsibilities 
       ("PDMR") / person closely associated ("PCA") 
 a)   Name                             Catherine Nicholson 
     -------------------------------  ---------------------------------- 
 2.   Reason for the Notification 
     ------------------------------------------------------------------- 
 a)   Position/status                  PCA of Ian Nicholson, Chairman 
     -------------------------------  ---------------------------------- 
 b)   Initial notification/Amendment   Initial notification 
     -------------------------------  ---------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------- 
 a)   Name                             Bioventix plc 
     -------------------------------  ---------------------------------- 
 b)   LEI                              213800225MHX7LZQY108 
     -------------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------- 
 a)   Description of the               Ordinary Shares of 5 pence each 
       Financial instrument, 
       type of instrument 
      Identification code              GB00B4QVDF07 
     -------------------------------  ---------------------------------- 
 b)   Nature of the transaction        Sale of Ordinary Shares 
     -------------------------------  ---------------------------------- 
 c)   Price(s) and volume(s)            Price(s)   Volume(s) 
                                         3,915p     1,500 
                                                   ---------- 
     -------------------------------  ---------------------------------- 
 d)        Aggregated information:     See 4(c) 
             *    Aggregated volume 
 
 
             *    Price 
     -------------------------------  ---------------------------------- 
 e)   Date of the transaction          31 March 2023 
     -------------------------------  ---------------------------------- 
 f)   Place of the transaction         London Stock Exchange, AIM Market 
                                        (XLON) 
     -------------------------------  ----------------------------------

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHEADDFDLFDEFA

(END) Dow Jones Newswires

March 31, 2023 09:45 ET (13:45 GMT)

Bioventix (AQSE:BVXP.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Bioventix Charts.
Bioventix (AQSE:BVXP.GB)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Bioventix Charts.